ATM and type 2 diabetes mellitus: Our findings may have translational potential as we previously showed this IR-ATM signature shows a strong overlap with that found in a meta-analysis of T2D patients [22]; suggesting TXN treatment could benefit obese patients with Type 2 Diabetes.